Emtricitabine, rilpivirine, and tenofovir and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Emtricitabine, rilpivirine, and tenofovir and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / rilpivirine / tenofovir
Brand name: Complera, Odefsey
Synonyms: Emtricitabine, Rilpivirine, and Tenofovir Disoproxil Fumarate
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emtricitabine, rilpivirine, and tenofovir-Insulin degludec
- Emtricitabine, rilpivirine, and tenofovir-Insulin Degludec (U-100) Prefilled Pens
- Emtricitabine, rilpivirine, and tenofovir-Insulin Degludec (U-100) Vials
- Emtricitabine, rilpivirine, and tenofovir-Insulin Degludec (U-200) Prefilled Pens
- Emtricitabine, rilpivirine, and tenofovir-Insulin degludec and liraglutide
- Emtricitabine, rilpivirine, and tenofovir-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Emtricitabine, Rilpivirine, and Tenofovir Alafenamide
- Insulin aspart, recombinant Subcutaneous-Emtricitabine, Rilpivirine, and Tenofovir Disoproxil Fumarate
- Insulin aspart, recombinant Subcutaneous-Emtriva
- Insulin aspart, recombinant Subcutaneous-Emtriva (Emtricitabine Capsules)
- Insulin aspart, recombinant Subcutaneous-Emtriva (Emtricitabine Solution)
- Insulin aspart, recombinant Subcutaneous-Emverm